Operational sustainability is severely compromised, evidenced by a $305.2K negative free cash flow in 2026Q1 and a total cash balance that has dwindled to just $24,600.
| Cash from Operations | -681.97K | -608.39K | -851.45K | -204 | -97.16K |
| Operating CF Margin % | - | - | -79.89% | - | - |
| Operating CF Growth % | -63.88% | 28.55% | -417275.49% | 99.79% | - |
| Net Income | 6.21M | 6.36M | -71.01K | -485.55K | -71 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -7.15M | -7.31M | -120.63K | 482.34K | -97.02K |
| Working Capital Changes | 258.88K | 336.15K | -659.81K | 3.01K | -75 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -609 | 29.01K | -449.75K | 0 | 0 |
| Cash from Investing | 0 | 0 | -174.22M | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 0% | - | - |
| Acquisitions | 0 | - | - | - | - |
| Investments | 183.27M | 181.66M | 174.35M | 0 | 0 |
| Other Investing | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 500K | 200K | 175.51M | 0 | 99.39K |
| Debt Issued (Net) | 0 | - | - | - | - |
| Equity Issued (Net) | 0 | 0 | 169.05M | 0 | -125.61K |
| Dividends Paid | -1.84M | 0 | -125.35K | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.84M | 0 | 6.98M | 0 | 0 |
| Net Change in Cash | -181.97K | -408.39K | 436.15K | -204 | 2.23K |
| Free Cash Flow | -681.97K | -608.39K | -851.45K | -204 | -145 |
| FCF Margin % | - | - | -79.89% | - | - |
| FCF Growth % | 37.03% | 28.55% | -417275.49% | -40.69% | - |
| FCF per Share | -0.04 | -0.04 | -0.21 | -0.00 | -0.00 |
| FCF Conversion (FCF/Net Income) | -0.11x | -0.10x | 11.99x | 0.00x | 1.38x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Insolvency and delisting risk
According to recent SEC filings, TDAC's reported net income of $1.3M in 2026Q1 stands in stark contrast to an operating cash outflow of $305.2K, highlighting a significant divergence that suggests the reported earnings are driven by non-operating accounting adjustments rather than any underlying cash-generating business activity.
The persistent negative OCF/NI ratio indicates that the company is not generating cash from its operations, which is expected for a shell entity. Investors should interpret the positive net income figures as accounting artifacts that do not reflect the actual liquidity position or the viability of the business model.
As reported in financial statements, TDAC has consistently recorded negative free cash flow, with a $305.2K outflow in 2026Q1, confirming that the entity is consuming its limited capital reserves to maintain its public listing status without any offsetting revenue or operational cash inflows to support the burn.
The lack of a positive FCF trajectory underscores the speculative nature of the investment, as the company remains entirely dependent on external funding. This trend suggests that the entity is effectively a cash-burning vehicle that requires an immediate business combination to avoid total depletion of its remaining assets.
Based on TDAC's reported figures, working capital changes have been erratic, including a $24.0K outflow in 2026Q1, which appears to reflect the irregular timing of professional service payments rather than any meaningful operational cycle or efficiency in managing current assets and liabilities within the shell structure.
The volatility in working capital movements suggests that the company is struggling to manage its administrative obligations as cash reserves dwindle. This pattern warrants further investigation into whether the company is deferring essential legal or audit costs to preserve its remaining $29,787 in cash.
As indicated by the financial data, the $1.8M dividend payment in 2025Q2 appears highly anomalous for a pre-revenue shell company, suggesting a potential return of capital that may have further strained the entity's already precarious liquidity position and limited its ability to fund future acquisition-related expenses.
The decision to distribute capital while maintaining no operational revenue is unusual and may indicate a lack of clear strategic direction regarding the use of sponsor-provided funds. This deployment strategy appears to have significantly weakened the balance sheet, leaving the company with minimal resources to pursue its stated translational biotech mandate.
Quick answers to the most common questions about buying TDAC stock.
Translational Development Acquisition Corp. (TDAC) generated $-0.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Translational Development Acquisition Corp. (TDAC) reported negative free cash flow of $0.6M in 2025, indicating capital requirements exceeded cash from operations.
Translational Development Acquisition Corp. (TDAC) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.